Biotechnology
Lipella is a clinical-stage biotechnology company dedicated to the discovery, development, and commercialization of lipid-based therapies for common bladder syndromes including interstitial cystitis (IC), refractory overactive bladder (OAB), and hemorrhagic cystitis (HC).